• Efficacy and Safety of Rivaroxaban Versus Aspirin in Embolic Stroke of Undetermined Source and Carotid Atherosclerosis 

      Ntaios G., Swaminathan B., Berkowitz S.D., Gagliardi R.J., Lang W., Siegler J.E., Lavados P., Mundl H., Bornstein N., Meseguer E., Amarenco P., Cucchiara B., Camps-Renom P., Makaritsis K., Korompoki E., Papavasileiou V., Marti-Fabregas J., Milionis H., Vemmos K., Connolly S.J., Hart R.G. (2019)
      Background and Purpose - The sources of emboli in patients with embolic stroke of undetermined source (ESUS) are multiple and may not respond uniformly to anticoagulation. In this exploratory subgroup analysis of patients ...